Skip to main content
. 2020 Mar 26;10(4):180. doi: 10.3390/diagnostics10040180

Table 4.

Prevalence of suspicious features in benign and malignant groups.

US Characteristic Benign Malignant
Blurred margins 28 (28.57%) 13 (37%)
Microcalcification 9 (9.1%) 11 (31.4%)
Marked Hypoechoic 3 (3.06%) 9 (25.7%)
Taller-than-wide 15 (15.3%) 15 (42.8%)
SR (>4) 12 (12.24%) 28 (80%)
4D: increased intranodular Vascularity/interrupted capsule 14 (14.28%) 23 (65%)